Yuriy Fedorov (Yuriy Federov)

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 14

Top Topics

Multiple Myeloma

Histone Deacetylase

Top Venues

Cancer research communications

Nature neuroscience

Nature chemical biology

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Priyanka S Rana, James J Ignatz-Hoover, Byung-Gyu Kim, Ehsan Malek, Yuriy Fedorov, Drew J Adams, Timothy A Chan, James J Driscoll
HDAC6 inhibition releases HR23B to activate proteasomes, expand the tumor immunopeptidome and amplify T-cell antimyeloma activity. Cancer research communications (2024)
Erin F Cohn, Benjamin L L Clayton, Mayur Madhavan, Kristin A Lee, Sara Yacoub, Yuriy Fedorov, Marissa A Scavuzzo, Katie Paul Friedman, Timothy J Shafer, Paul J Tesar
Pervasive environmental chemicals impair oligodendrocyte development. Nature neuroscience (2024)
Erin F Cohn, Benjamin L L Clayton, Mayur Madhavan, Kristin A Lee, Sara Yacoub, Yuriy Fedorov, Marissa A Scavuzzo, Katie Paul Friedman, Timothy J Shafer, Paul J Tesar
Pervasive environmental chemicals impair oligodendrocyte development. Nature neuroscience 27 (5) (2024)
Erin F Cohn, Benjamin L L Clayton, Mayur Madhavan, Kristin A Lee, Sara Yacoub, Yuriy Fedorov, Marissa A Scavuzzo, Katie Paul Friedman, Timothy J Shafer, Paul J Tesar
Pervasive environmental chemicals impair oligodendrocyte development. Nature neuroscience 27 (5) (2024)
Erin F Cohn, Benjamin L L Clayton, Mayur Madhavan, Kristin A Lee, Sara Yacoub, Yuriy Fedorov, Marissa A Scavuzzo, Katie Paul Friedman, Timothy J Shafer, Paul J Tesar
Pervasive environmental chemicals impair oligodendrocyte development. Nature neuroscience 27 (5) (2024)
Erin F Cohn, Benjamin L L Clayton, Mayur Madhavan, Kristin A Lee, Sara Yacoub, Yuriy Fedorov, Marissa A Scavuzzo, Katie Paul Friedman, Timothy J Shafer, Paul J Tesar
Pervasive environmental chemicals impair oligodendrocyte development. Nature neuroscience (2024)
Priyanka S Rana, James J Ignatz-Hoover, Byung-Gyu Kim, Ehsan Malek, Yuriy Fedorov, Drew J Adams, Timothy A Chan, James J Driscoll
HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity. Cancer research communications 4 (6) (2024)
Erin F Cohn, Benjamin L L Clayton, Mayur Madhavan, Kristin A Lee, Sara Yacoub, Yuriy Fedorov, Marissa A Scavuzzo, Katie Paul Friedman, Timothy J Shafer, Paul J Tesar
Pervasive environmental chemicals impair oligodendrocyte development. Nature neuroscience 27 (5) (2024)
Priyanka S Rana, James J Ignatz-Hoover, Byung-Gyu Kim, Ehsan Malek, Yuriy Fedorov, Drew J Adams, Timothy A Chan, James J Driscoll
HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity. Cancer research communications 4 (6) (2024)
Yi Fan Chen, Maryam Ghazala, Ryan M Friedrich, Brittany A Cordova, Frederick N Petroze, Ramya Srinivasan, Kevin C Allan, David F Yan, Joel L Sax, Kelley Carr, Suzanne L Tomchuck, Yuriy Fedorov, Alex Y Huang, Amar B Desai, Drew J Adams
Targeting the chromatin binding of exportin-1 disrupts NFAT and T cell activation. Nature chemical biology (2024)
Priyanka S Rana, James J Ignatz-Hoover, Byung-Gyu Kim, Ehsan Malek, Yuriy Fedorov, Drew J Adams, Timothy A Chan, James J Driscoll
HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity. Cancer research communications 4 (6) (2024)
Priyanka S Rana, James J Ignatz-Hoover, Byung-Gyu Kim, Ehsan Malek, Yuriy Fedorov, Drew J Adams, Timothy A Chan, James J Driscoll
HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity. Cancer research communications 4 (6) (2024)
Priyanka S Rana, James J Ignatz-Hoover, Chunna Guo, Amber L Mosley, Ehsan Malek, Yuriy Fedorov, Drew J Adams, James J Driscoll
Immunoproteasome activation expands the MHC class I immunopeptidome, unmasks neoantigens and enhances T-cell antimyeloma activity. Molecular cancer therapeutics (2024)
Priyanka S Rana, James J Ignatz-Hoover, Byung-Gyu Kim, Ehsan Malek, Yuriy Fedorov, Drew J Adams, Timothy A Chan, James J Driscoll
HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity. Cancer research communications 4 (6) (2024)